Paeds SAQs · genetics-dysmorphology-and-metabolism
Hypoglycaemia due to inherited metabolic disease — formative SAQs
Formative SAQs on recognising hypoketotic hypoglycaemia as a metabolic emergency, capturing the critical sample before treating, classifying the cause into insulin-driven, glucose-production failure, and fuel-oxidation block, and delivering disease-specific therapy with diazoxide, carnitine and cornstarch.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A 14-month-old boy is brought to the emergency department after being found unresponsive in his cot in the morning. He had a viral illness with poor oral intake for 36 hours. On examination he is seizing, with a bedside glucose of 1.1 mmol/L. He has mild hepatomegaly. The team draws bloods before treating: insulin detectable, beta-hydroxybutyrate 0.3 mmol/L, free fatty acids markedly elevated, lactate normal, ammonia normal. [1] [6]
a) Explain why this biochemical profile — hypoglycaemia with inappropriately low ketones but high free fatty acids — points to a fatty-acid oxidation defect, and name the most likely diagnosis. (3 marks) [6] [1]
b) Describe the immediate resuscitation you deliver, and justify why a critical sample was drawn before treatment. (3 marks) [1]
c) Outline the long-term management plan, including the emergency sick-day advice you give the family. (2 marks) [6]
d) Explain the significance of this presentation for the family, including recurrence risk and the role of newborn screening. (2 marks) [6] [1]
References4ShowHide
- [1]Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr, 2015.PMID 25957977
- [2]Kapoor RR, Flanagan SE, Arya VB, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol, 2013.PMID 23345197
- [6]Spiekerkoetter U, Bastin J, Gillingham M, et al. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis, 2010.PMID 20830526
- [4]Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol, 2010.PMID 20975743